Characterizing white matter alterations subject to clinical laterality in drug-naive de novo Parkinson’s disease

Characterizing white matter alterations subject to clinical laterality in drug-naive de novo Parkinson’s disease
Hum Brain Mapp. 2021 Jun 9. doi: 10.1002/hbm.25558. Online ahead of print.ABSTRACTParkinson's disease (PD) is a progressive neurodegenerative disorder that is characterized by a range of motor and nonmotor symptoms, often with the motor dysfunction initiated unilaterally. Knowledge regarding disease-related alterations in white matter pathways can effectively help improve the understanding of the disease and propose targeted treatment strategies. Microstructural ... read more
Source: PubMedPublished on 2021-06-09By Yiming Xiao